Synthetic Biologics, Inc. (SYN) CEO Steven Shallcross on Q1 2022 Results - Earnings Call Transcript

Synthetic Biologics, Inc. (NYSE:NYSE:SYN) Q1 2022 Earnings Conference Call May 16, 2022, 09:00 AM ET Company Participants Dean Schwartz - LifeSci Advisors, IR Steven Shallcross - CEO and...

Related Keywords

Mexico ,Australia ,Japan ,United States ,Israel ,Washu ,Guangdong ,China ,Washington ,Canada ,Russia ,South Korea ,American ,Jason Mccarthy ,Frank Tufaro ,Vince Wacher ,Leland Gershell ,Manel Cascallo ,Jo Anne Lee ,Steven Shallcross ,Manuel Hidalgo ,Jim Molloy ,Company Participants ,Product Development Of Synthetic Biologics ,Alliance Global Partners ,University At Leeds ,Meeting Of The American Society Gene ,Exchange Commission ,Washington University ,Maxim Group ,European Medicines Agency ,University Of Pennsylvania ,University Of Leeds ,Synthetic Biologics Inc ,Division Of Hematology ,Synthetic Biologics ,Conference Call May ,Sci Advisors ,Synthetic Biologic First Quarter ,Dean Schwartz ,Chief Executive ,Chief Financial Officer ,Product Development ,General Director ,European Subsidiary ,Chief Operating Officer ,Synthetic Biologic ,Scientific Advisory Board ,Orphan Drug Act ,Medical Oncology ,Weill Cornell Medicine New York Presbyterian ,Annual Meeting ,American Society ,Cell Therapy ,Alliance Global ,